Wall Street Analyst Thinks Pfizer Stock Could Soar 38% This Week
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Review worst-case drawdown scenarios for retirees using index funds and outline strategies to mitigate impact and preserve long-term goals.
20,058 articlesA single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
As tech’s power demand surges, data centers are becoming a bigger profit driver for utilities, prompting fresh debate...
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
A Sunday morning design segment examines how style choices affect wallets—from backyard ADUs to luxury interiors—and ...
With the CLARITY Act stalled in Congress, experts warn that a full U.S. crypto regulatory framework could slip past 2...
This article breaks down APi Group's Q1 2026 earnings call, translating the numbers into actionable takeaways for inv...
BWLP’s Q1 2026 results offer a window into fleet utilization, charter rates, and balance-sheet moves. This guide brea...
CrowdStrike is set to report Q1 results after the close, with analysts expecting revenue around $1.39 billion and sol...
As Sprinklr (CXM) gears up for 2027 earnings, investors will scrutinize revenue growth, margins, and customer stickin...
In May, iren limited rallied almost 40% as investors priced in AI growth, earnings signals, and a new Nvidia partners...